Toggle navigation
Home
Search
Services
Blog
Contact
About
A Standard Repository of DNA for Human Gene Mapping
Kouri, Richard Ellis
Genaissance Pharmaceuticals, Inc., New Haven, CT, United States
Search 10 grants from Richard Kouri
Search grants from Genaissance Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Functional MRI Studies of Emotion in Depression and Rapid Antidepressant Response
Molecular Dynamics Conformation Of Opioid Peptides
Family Based Prevention for Childhood Anxiety
Molecular Characterization of Murine Pcy Mutation
Geometric and quantum topology in low dimensions
Recently added grants:
Metabolomics Core
Host Factors in Response to Therapeutic Monoclonal Antibodies and Vaccination
Allergen T cell epitopes during the management of peanut allergic disease
Development of FRESH (Fast Rescue Employing Self-Helper virus) - a rapid, generalizable method to rescue infectious virus from noninfectious genomic material
Allergen T cell epitopes during the management of peanut allergic disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44CA040853-02A5
Application #
3506454
Study Section
(SSS)
Project Start
1989-09-22
Project End
1991-08-31
Budget Start
1989-09-22
Budget End
1990-08-31
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Institution
Name
Genaissance Pharmaceuticals, Inc.
Department
Type
DUNS #
City
New Haven
State
CT
Country
United States
Zip Code
06511
Related projects
NIH 1990
R44 CA
A Standard Repository of DNA for Human Gene Mapping
Kouri, Richard Ellis / Genaissance Pharmaceuticals, Inc.
NIH 1989
R44 CA
A Standard Repository of DNA for Human Gene Mapping
Kouri, Richard Ellis / Genaissance Pharmaceuticals, Inc.
Comments
Be the first to comment on Richard Kouri's grant